Current knowledge of trichosporon spp. and trichosporonosis

Clinical Microbiology Reviews

Volumn 24, Issue 4, 2011, Pages 682-700

  Colombo, Arnaldo L ^a   Padovan, Ana Carolina B ^a   Chaves, Guilherme M ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ANTIGEN DETECTION; BIOFILM; FUNCTIONAL PROTEOMICS; FUNGAL CELL; FUNGAL DEVELOPMENT; HUMAN; LABORATORY TEST; MYCOSIS; NONHUMAN; NOTE; PHENOTYPE; POLYMERASE CHAIN REACTION; TRICHOSPORON; TRICHOSPORONOSIS;

ANIMALS; ANTIFUNGAL AGENTS; HUMANS; TRIAZOLES; TRICHOSPORON; TRICHOSPORONOSIS;

EID: 80053580681     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00003-11     Document Type: Note

References (198)

1. Abdala, E., R. I. Lopes, C. N. Chaves, E. M. Heins-Vaccari, and M. A. Shikanai-Yasuda. 2005. Trichosporon asahii fatal infection in a non-neutropenic patient after orthotopic liver transplantation. Transpl. Infect. Dis. 7:162-165.
2. Ahmad, S., M. Al-Mahmeed, and Z. U. Khan. 2005. Characterization of Trichosporon species isolated from clinical specimens in Kuwait. J. Med. Microbiol. 54:639-646.
3. Anaissie, E., et al. 1992. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review. Clin. Infect. Dis. 15:781-787.
4. Anderson, J.M., and D. R. Soll. 1987. Unique phenotype of opaque cells in the white-opaque transition of Candida albicans. J. Bacteriol. 169:5579-5588.
5. Ando, M., K. Arima, R. Yoneda, and M. Tamura. 1991. Japanese summer-type hypersensitivity pneumonitis. Geographic distribution, home environment, and clinical characteristics of 621 cases. Am. Rev. Respir. Dis. 144:765-769.
6. Ando, M., et al. 1990. Serotype-related antigen of Trichosporon cutaneum in the induction of summer-type hypersensitivity pneumonitis: correlation between serotype of inhalation challenge-positive antigen and that of the isolates from patients' homes. J. Allergy Clin. Immunol. 85:36-44.
7. Arai, T., S. Yusa, K. Kirimura, and S. Usami. 1997. Cloning and sequencing of the cDNA encoding lipase I from Trichosporon fermentans WU-C12. FEMS Microbiol. Lett. 152:183-188.
8. Araujo Ribeiro, M., A. Alastruey-Izquierdo, A. Gomez-Lopez, J. L. Rodriguez-Tudela, and M. Cuenca-Estrella. 2008. Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital. Rev. Iberoam. Micol. 25:221-225.
9. Archer-Dubon, C., et al. 2003. Superficial mycotic infections of the foot in a native pediatric population: a pathogenic role for Trichosporon cutaneum? Pediatr. Dermatol. 20:299-302.
10. Arikan, S., and G. Hascelik. 2002. Comparison of NCCLS microdilution method and Etest in antifungal susceptibility testing of clinical Trichosporon asahii isolates. Diagn. Microbiol. Infect. Dis. 43:107-111.
11. Arikawa, T., et al. 2010. Galectin-9 expands immunosuppressive macrophages to ameliorate T-cell-mediated lung inflammation. Eur. J. Immunol. 40:548-558.
12. Asada, N., et al. 2006. Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia. Clin. Infect. Dis. 43:39-41.
13. Bader, O., et al. 2010. Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-offlight mass spectrometry. Clin. Microbiol. Infect. in press.
14. Bassetti, M., et al. 2004. Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B. J. Antimicrob. Chemother. 54:575-577.
15. Bayramoglu, G., M. Sonmez, I. Tosun, K. Aydin, and F. Aydin. 2008. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin. Infection 36:68-70.
16. Behrend, G. 1890. Ueber Trichomycosis nodosa (Juhel-Rénoy): Piedra (Osorio). Klin. Wschr. 27:464-467.
17. Benson, P. M., N. A. Lapins, and R. B. Odom. 1983. White piedra. Arch. Dermatol. 119:602-604.
18. BioMérieux. 2006. ID 32 C-identification system for yeasts. bioMérieux, Marcy l'Etoile, France.
19. BioMérieux. 2008. Identification VITEK 2 YST CARD. bioMérieux, Marcy l'Etoile, France.
20. Biswas, S. K., L. Wang, K. Yokoyama, and K. Nishimura. 2005. Molecular phylogenetics of the genus Trichosporon inferred from mitochondrial cytochrome B gene sequences. J. Clin. Microbiol. 43:5171-5178.
21. Bruker Daltonics. 2008. MALDI Biotyper user manual, version 2.0 SR1. Bruker Daltonik GmbH, Bremen, Germany.
22. Cafarchia, C., D. Romito, C. Coccioli, A. Camarda, and D. Otranto. 2008. Phospholipase activity of yeasts from wild birds and possible implications for human disease. Med. Mycol. 46:429-434.
23. Cawley, M. J., et al. 2000. Trichosporon beigelii infection: experience in a regional burn center. Burns 26:483-486.
24. Chagas-Neto, T. C., G. M. Chaves, and A. L. Colombo. 2008. Update on the genus Trichosporon. Mycopathologia 166:121-132.
25. Chagas-Neto, T. C., G. M. Chaves, A. S. Melo, and A. L. Colombo. 2009. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing. J. Clin. Microbiol. 47:1074-1081.
26. Chakrabarti, A., et al. 2002. Generalized lymphadenopathy caused by Trichosporon asahii in a patient with Job's syndrome. Med. Mycol. 40:83-86.
27. Chan, R. M., P. Lee, and J. Wroblewski. 2000. Deep-seated trichosporonosis in an immunocompetent patient: a case report of uterine trichosporonosis. Clin. Infect. Dis. 31:621.
28. Chaturvedi, V., R. Ramani, and J. H. Rex. 2004. Collaborative study of antibiotic medium 3 and flow cytometry for identification of amphotericin B-resistant Candida isolates. J. Clin. Microbiol. 42:2252-2254.
29. Chaumentin, G., et al. 1996. Trichosporon inkin endocarditis: short-term evolution and clinical report. Clin. Infect. Dis. 23:396-397.
30. Chaves, G. M., M. A. Q. Cavalcanti, and A. L. F. Porto. 2003. Pathogenicity characteristics of stocked and fresh yeasts strains. Braz. J. Microbiol. 34: 197-202.
31. Chen, J., S. Shimura, K. Kirimura, and S. Usami. 1994. Purification of extracellular lipases from Trichosporon fermentans WU-C12. J. Ferment. Bioengin. 77:548-550.
32. Christakis, G., S. Perlorentzou, M. Aslanidou, A. Megalakaki, and A. Velegraki. 2005. Fatal Blastoschizomyces capitatus sepsis in a neutropenic patient with acute myeloid leukemia: first documented case from Greece. Mycoses 48:216-220.
33. Ciardo, D. E., G. Schar, E. C. Bottger, M. Altwegg, and P. P. Bosshard. 2006. Internal transcribed spacer sequencing versus biochemical profiling for identification of medically important yeasts. J. Clin. Microbiol. 44:77-84.
34. Colombo, A. L., et al. 1996. Gastrointestinal translocation as a possible source of candidemia in an AIDS patient. Rev. Inst. Med. Trop. Sao Paulo 38:197-200.
35. Cornely, O. A., K. Schmitz, and S. Aisenbrey. 2002. The first echinocandin: caspofungin. Mycoses 45:56-60.
36. Cuenca-Estrella, M., et al. 2003. Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clin. Microbiol. Infect. 9:467-474.
37. Daǧ, A., and N. Cerikc ̧iog ̌lu. 2006. Investigation of some virulence factors of Trichosporon asahii strains isolated from the clinical samples of hospitalized patients. Mikrobiyol. Bul. 40:225-235.
38. De Hoog, G. S., M. T. Smith, and E. Gueho. 1986. A revision of the genus Geotrichum and its teleomorphs. Stud. Mycol. 29:1-131.
39. De Hoogs, G. S., J. Guarro, J. Gene, and M. J. Figueras. 2000. Atlas of clinical fungi, 2nd ed. Guanabara, Rio de Janeiro, Brazil.
40. De Pauw, B., et al. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46:1813-1821.
41. Diaz, M. R., and J. W. Fell. 2004. High-throughput detection of pathogenic yeasts of the genus Trichosporon. J. Clin. Microbiol. 42:3696-3706.
42. Di Bonaventura, G., et al. 2006. Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. Antimicrob. Agents Chemother. 50:3269-3276.
43. Dooley, D. P., M. L. Beckius, and B. S. Jeffrey. 1994. Misidentification of clinical yeast isolates by using the updated Vitek Yeast Biochemical Card. J. Clin. Microbiol. 32:2889-2892.
44. Ebright, J. R., M. R. Fairfax, and J. A. Vazquez. 2001. Trichosporon asahii, a non-Candida yeast that caused fatal septic shock in a patient without cancer or neutropenia. Clin. Infect. Dis. 33:E28-E30.
45. Ellner, K., M. E. McBride, T. Rosen, and D. Berman. 1991. Prevalence of Trichosporon beigelii. Colonization of normal perigenital skin. J. Med. Vet. Mycol. 29:99-103.
46. Erer, B., et al. 2000. Trichosporon beigelii: a life-threatening pathogen in immunocompromised hosts. Bone Marrow Transplant. 25:745-749.
47. Espinel-Ingroff, A. 1998. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J. Clin. Microbiol. 36:2950-2956.
48. Espinel-Ingroff, A., et al. 1998. Comparison of RapID yeast plus system with API 20C system for identification of common, new, and emerging yeast pathogens. J. Clin. Microbiol. 36:883-886.
49. EUCAST. 2008. European Committee on Antimicrobial Susceptibility Testing. EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin. Microbiol. Infect. 14:398-405.
50. Febre, N., et al. 1999. Microbiological characteristics of yeasts isolated from urinary tracts of intensive care unit patients undergoing urinary catheterization. J. Clin. Microbiol. 37:1584-1586.
51. Fell, J. W., and G. Scorzetti. 2004. Reassignment of the basidiomycetous yeasts Trichosporon pullulans to Guehomyces pullulans gen. nov., comb. nov. and Hyalodendron lignicola to Trichosporon lignicola comb. nov. Int. J. Syst. Evol. Microbiol. 54:995-998.
52. Fenn, J., et al. 1994. Comparison of updated Vitek yeast biochemical card and API 20C yeast identification system. J. Clin. Microbiol. 32:1184-1187.
53. Fischman, O. 1973. Black piedra among Brazilian Indians. Rev. Inst. Med. Trop. Sao Paulo 15:103-106.
54. Fischman, O. 1965. Black piedra in Brazil. A contribution to its study in Manaus (state of Amazonas). Mycopathol. Mycol. Appl. 25:201-204.
55. Fleming, R. V., T. J. Walsh, and E. J. Anaissie. 2002. Emerging and less common fungal pathogens. Infect. Dis. Clin. North Am. 16:915-933.
56. Fonseca, F. L., et al. 2009. Structural and functional properties of the Trichosporon asahii glucuronoxylomannan. Fungal Genet. Biol. 46:496-505.
57. Fournier, S., et al. 2002. Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia. Eur. J. Clin. Microbiol. Infect. Dis. 21:892-896.
58. Fox, A. 2006. Mass spectrometry for species or strain identification after culture or without culture: past, present, and future. J. Clin. Microbiol. 44:2677-2680.
59. Fries, B. C., D. L. Goldman, R. Cherniak, R. Ju, and A. Casadevall. 1999. Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure. Infect. Immun. 67: 6076-6083.
60. Fuentefria, A. M., et al. 2008. Trichosporon insectorum sp. nov., a new anamorphic basidiomycetous killer yeast. Mycol. Res. 112:93-99.
61. Ghannoum, M. A. 2000. Potential role of phospholipases in virulence and fungal pathogenesis. Clin. Microbiol. Rev. 13:122-143.
62. Girmenia, C., et al. 2005. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J. Clin. Microbiol. 43:1818-1828.
63. Gold, I., B. Sommer, S. Urson, and M. Schewach-Millet. 1984. White piedra. A frequently misdiagnosed infection of hair. Int. J. Dermatol. 23: 621-623.
64. Goodman, D., E. Pamer, A. Jakubowski, C. Morris, and K. Sepkowitz. 2002. Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate. Clin. Infect. Dis. 35:35-36.
65. Groll, A. H., and T. J. Walsh. 2001. Uncommon opportunistic fungi: new nosocomial threats. Clin. Microbiol. Infect. 7(Suppl. 2):8-24.
66. Gueho, E., G. S. de Hoog, and M. T. Smith. 1992. Neotypification of the genus Trichosporon. Antonie Van Leeuwenhoek 61:285-288.
67. Gueho, E., L. Improvisi, G. S. de Hoog, and B. Dupont. 1994. Trichosporon on humans: a practical account. Mycoses 37:3-10.
68. Gueho, E., M. T. Smith, and G. S. de Hoog. 1998. Trichosporon Behrend, p. 854-872. In C. P. Kurtzman and J. W. Fell (ed.), The yeasts, a taxonomic study, 4th ed. Elsevier, Amsterdam, The Netherlands.
69. Gueho, E., et al. 1992. Contributions to a revision of the genus Trichosporon. Antonie Van Leeuwenhoek 61:289-316.
70. Gujjari, P., S. O. Suh, K. Coumes, and J. J. Zhou. 10 May 2011, posting date. Characterization of oleaginous yeasts revealed two novel species: Trichosporon cacaoliposimilis sp. nov. and Trichosporon oleaginosus sp. nov. Mycologia doi:10.3852/10-403.
71. Gujjari, P., S. O. Suh, C. F. Lee, and J. J. Zhou. 29 October 2010, posting date. Trichosporon xylopini sp. nov., a hemicellulose-degrading yeast isolated from wood-inhabiting beetle Xylopinus saperdioides. Int. J. Syst. Evol. Microbiol. doi:10.1099/ijs.0.028860-0.
72. Gundes, S. G., S. Gulenc, and R. Bingol. 2001. Comparative performance of Fungichrom I, Candifast and API 20C Aux systems in the identification of clinically significant yeasts. J. Med. Microbiol. 50:1105-1110.
73. Hajjeh, R. A., and H. M. Blumberg. 1995. Bloodstream infection due to Trichosporon beigelii in a burn patient: case report and review of therapy. Clin. Infect. Dis. 20:913-916.
74. Hara, S., et al. 2007. Endophthalmitis due to Trichosporon beigelii in acute leukemia. Int. J. Hematol. 85:415-417.
75. Hata, K., et al. 1996. In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum. Antimicrob. Agents Chemother. 40:2237-2242.
76. Haupt, H. M., W. G. Merz, W. E. Beschorner, W. P. Vaughan, and R. Saral. 1983. Colonization and infection with Trichosporon species in the immunosuppressed host. J. Infect. Dis. 147:199-203.
77. Hogan, L. H., B. S. Klein, and S. M. Levitz. 1996. Virulence factors of medically important fungi. Clin. Microbiol. Rev. 9:469-488.
78. Holland, S. M., Y. R. Shea, and J. Kwon-Chung. 2004. Regarding ''Trichosporon pullulans infection in 2 patients with chronic granulomatous disease.'' J. Allergy Clin. Immunol. 114:205-206. (Author reply, 114:206.)
79. Hosoki, K., S. Iwamoto, T. Kumamoto, E. Azuma, and Y. Komada. 2008. Early detection of breakthrough trichosporonosis by serum PCR in a cord blood transplant recipient being prophylactically treated with voriconazole. J. Pediatr. Hematol. Oncol. 30:917-919.
80. Hospenthal, D. R., C. K. Murray, and M. G. Rinaldi. 2004. The role of antifungal susceptibility testing in the therapy of candidiasis. Diagn. Microbiol. Infect. Dis. 48:153-160.
81. Hoy, J., et al. 1986. Trichosporon beigelii infection: a review. Rev. Infect. Dis. 8:959-967.
82. Hsiue, H. C., et al. 2010. Rapid identification of fungal pathogens in positive blood cultures using oligonucleotide array hybridization. Clin. Microbiol. Infect. 16:493-500.
83. Huang, L. U., et al. 2001. A comparison of methods for yeast identification including CHROMagar Candida, Vitek system YBC and a traditional biochemical method. Zhonghua Yi Xue Za Zhi (Taipei) 64:568-574.
84. Ichikawa, T., et al. 2004. Phenotypic switching and beta-N-acetylhexosaminidase activity of the pathogenic yeast Trichosporon asahii. Microbiol. Immunol. 48:237-242.
85. Ikeda, R., M. Yokota, and T. Shinoda. 1996. Serological characterization of Trichosporon cutaneum and related species. Microbiol. Immunol. 40:813-819.
86. Izumi, K., Y. Hisata, and S. Hazama. 2009. A rare case of infective endocarditis complicated by Trichosporon asahii fungemia treated by surgery. Ann. Thorac. Cardiovasc. Surg. 15:350-353.
87. Jain, N., F. Hasan, and B. C. Fries. 2008. Phenotypic switching in fungi. Curr. Fungal Infect. Rep. 2:180-188.
88. Jian, D. Y., W. C. Yang, T. W. Chen, and C. C. Lin. 2008. Trichosporon asahii following polymicrobial infection in peritoneal dialysis-associated peritonitis. Perit. Dial. Int. 28:100-101.
89. Kalkanci, A., et al. 2010. Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogen Trichosporon isolated from Turkish patients. Med. Mycol. 48:141-146.
90. Kaltreider, H. B. 1993. Hypersensitivity pneumonitis. West. J. Med. 159: 570-578.
91. Karashima, R., et al. 2002. Increased release of glucuronoxylomannan antigen and induced phenotypic changes in Trichosporon asahii by repeated passage in mice. J. Med. Microbiol. 51:423-432.
92. Kataoka-Nishimura, S., et al. 1998. Invasive infection due to Trichosporon cutaneum in patients with hematologic malignancies. Cancer 82:484-487.
93. Keay, S., D. W. Denning, and D. A. Stevens. 1991. Endocarditis due to Trichosporon beigelii: in vitro susceptibility of isolates and review. Rev. Infect. Dis. 13:383-386.
94. Kemker, B. J., P. F. Lehmann, J. W. Lee, and T. J. Walsh. 1991. Distinction of deep versus superficial clinical and nonclinical isolates of Trichosporon beigelii by isoenzymes and restriction fragment length polymorphisms of rDNA generated by polymerase chain reaction. J. Clin. Microbiol. 29:1677-1683.
95. Khanna, R., D. G. Oreopoulos, S. Vas, D. McNeely, and W. McCready. 1980. Treating fungal infections. Br. Med. J. 280:1147-1148.
96. Kiken, D. A., et al. 2006. White piedra in children. J. Am. Acad. Dermatol. 55:956-961.
97. Kitch, T. T., M. R. Jacobs, M. R. McGinnis, and P. C. Appelbaum. 1996. Ability of RapID Yeast Plus system to identify 304 clinically significant yeasts within 5 hours. J. Clin. Microbiol. 34:1069-1071.
98. Kontoyiannis, D. P., et al. 2004. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand. J. Infect. Dis. 36:564-569.
99. Krcmery, V., Jr., et al. 1999. Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol. Support Care Cancer 7:39-43.
100. Kumar, S. S., L. Kumar, V. Sahai, and R. Gupta. 2009. A thiol-activated lipase from Trichosporon asahii MSR 54: detergent compatibility and presoak formulation for oil removal from soiled cloth at ambient temperature. J. Ind. Microbiol. Biotechnol. 36:427-432.
101. Kwon-Chung, K. J., and J. E. Bennett. 1992. Medical mycology. Lea & Febiger, Philadelphia, PA.
102. Land, G. A., I. F. Salkin, M. el-Zaatari, M. R. McGinnis, and G. Hashem. 1991. Evaluation of the Baxter-MicroScan 4-hour enzyme-based yeast identification system. J. Clin. Microbiol. 29:718-722.
103. Landlinger, C., et al. 2009. Species-specific identification of a wide range of clinically relevant fungal pathogens by use of Luminex xMAP technology. J. Clin. Microbiol. 47:1063-1073.
104. Leaw, S. N., H. C. Chang, R. Barton, J. P. Bouchara, and T. C. Chang. 2007. Identification of medically important Candida and non-Candida yeast species by an oligonucleotide array. J. Clin. Microbiol. 45:2220-2229.
105. Leaw, S. N., et al. 2006. Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J. Clin. Microbiol. 44:693-699.
106. Li, H., Q. Lu, Z. Wan, and J. Zhang. 2010. In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii. Int. J. Antimicrob. Agents 35:550-552.
107. Lopes, J. O., S. H. Alves, C. Klock, L. T. Oliveira, and N. R. Dal Forno. 1997. Trichosporon inkin peritonitis during continuous ambulatory peritoneal dialysis with bibliography review. Mycopathologia 139:15-18.
108. Lussier, N., M. Laverdiere, J. Delorme, K. Weiss, and R. Dandavino. 2000. Trichosporon beigelii funguria in renal transplant recipients. Clin. Infect. Dis. 31:1299-1301.
109. Lyman, C. A., et al. 1995. Detection and quantitation of the glucuronoxylomannan- like polysaccharide antigen from clinical and nonclinical isolates of Trichosporon beigelii and implications for pathogenicity. J. Clin. Microbiol. 33:126-130.
110. Macedo, D. P., et al. 2011. Trichosporon inkin esophagitis: an uncommon disease in a patient with pulmonary cancer. Mycopathologia 171:279-283.
111. Madariaga, M. G., A. Tenorio, and L. Proia. 2003. Trichosporon inkin peritonitis treated with caspofungin. J. Clin. Microbiol. 41:5827-5829.
112. Makino, H., J. Fujimoto, and K. Watanabe. 2010. Development and evaluation of a real-time quantitative PCR assay for detection and enumeration of yeasts of public health interest in dairy products. Int. J. Food Microbiol. 140:76-83.
113. Manzella, J. P., I. J. Berman, and M. D. Kukrika. 1982. Trichosporon beigelii fungemia and cutaneous dissemination. Arch. Dermatol. 118:343-345.
114. Marier, R., et al. 1978. Trichosporon cutaneum endocarditis. Scand. J. Infect. Dis. 10:225-226.
115. Marklein, G., et al. 2009. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J. Clin. Microbiol. 47:2912-2917.
116. Martinez-Lacasa, J., et al. 1991. Long-term survival of a patient with prosthetic valve endocarditis due to Trichosporon beigelii. Eur. J. Clin. Microbiol. Infect. Dis. 10:756-758.
117. Marty, F. M., D. H. Barouch, E. P. Coakley, and L. R. Baden. 2003. Disseminated trichosporonosis caused by Trichosporon loubieri. J. Clin. Microbiol. 41:5317-5320.
118. Matsue, K., H. Uryu, M. Koseki, N. Asada, and M. Takeuchi. 2006. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin. Clin. Infect. Dis. 42:753-757.
119. Mekha, N., et al. 2010. Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients. Mycopathologia 169:67-70.
120. Melcher, G. P., et al. 1991. Demonstration of a cell wall antigen crossreacting with cryptococcal polysaccharide in experimental disseminated trichosporonosis. J. Clin. Microbiol. 29:192-196.
121. Mendez-Tovar, L. J., et al. 2006. Micosis among five highly underprivileged Mexican communities. Gaceta Med. Mexico 142:381-386.
122. Meyer, M. H., et al. 2002. Chronic disseminated Trichosporon asahii infection in a leukemic child. Clin. Infect. Dis. 35:22-25.
123. Middelhoven, W. J., G. Scorzetti, and J. W. Fell. 2004. Systematics of the anamorphic basidiomycetous yeast genus Trichosporon Behrend with the description of five novel species: Trichosporon vadense, T. smithiae, T. dehoogii, T.scarabaeorum and T. gamsii. Int. J. Syst. Evol. Microbiol. 54:975-986.
124. Mizobe, T., M. Ando, H. Yamasaki, K. Onoue, and A. Misaki. 1995. Purification and characterization of the serotype-specific polysaccharide antigen of Trichosporon cutaneum serotype II: a disease-related antigen of Japanese summer-type hypersensitivity pneumonitis. Clin. Exp. Allergy 25:265-272.
125. Molnar, O., G. Schatzmayr, E. Fuchs, and H. Prillinger. 2004. Trichosporon mycotoxinivorans sp. nov., a new yeast species useful in biological detoxification of various mycotoxins. Syst. Appl. Microbiol. 27:661-671.
126. Moretti-Branchini, M. L., et al. 2001. Trichosporon species infection in bone marrow transplanted patients. Diagn. Microbiol. Infect. Dis. 39:161-164.
127. Mori, Y., et al. 2005. Marked renal damage in a child with hydronephrosis infected by Trichosporon asahii. Pediatr. Nephrol. 20:234-236.
128. Moylett, E. H., J. Chinen, and W. T. Shearer. 2003. Trichosporon pullulans infection in 2 patients with chronic granulomatous disease: an emerging pathogen and review of the literature. J. Allergy Clin. Immunol. 111:1370-1374.
129. Nagai, H., Y. Yamakami, A. Hashimoto, I. Tokimatsu, and M. Nasu. 1999. PCR detection of DNA specific for Trichosporon species in serum of patients with disseminated trichosporonosis. J. Clin. Microbiol. 37:694-699.
130. Nagano, Y., et al. 2010. Comparison of techniques to examine the diversity of fungi in adult patients with cystic fibrosis. Med. Mycol. 48:166-176.
131. Nakajima, M., T. Sugita, and Y. Mikami. 2007. Granuloma associated with Trichosporon asahii infection in the lung: unusual pathological findings and PCR detection of Trichosporon DNA. Med. Mycol. 45:641-644.
132. NCCLS/CLSI. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts. M27-A3, vol. 28. NCCLS/CLSI, Wayne, PA.
133. Nishiura, Y., et al. 1997. Assignment and serotyping of Trichosporon species: the causative agents of summer-type hypersensitivity pneumonitis. J. Med. Vet. Mycol. 35:45-52.
134. Nucci, M., and E. Anaissie. 2001. Revisiting the source of candidemia: skin or gut? Clin. Infect. Dis. 33:1959-1967.
135. Obana, Y., M. Sano, T. Jike, T. Homma, and N. Nemoto. 2010. Differential diagnosis of trichosporonosis using conventional histopathological stains and electron microscopy. Histopathology 56:372-383.
136. Odabasi, Z., et al. 2004. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin. Infect. Dis. 39:199-205.
137. Padhye, A. A., et al. 2003. Trichosporon loubieri infection in a patient with adult polycystic kidney disease. J. Clin. Microbiol. 41:479-482.
138. Pagano, L., et al. 2006. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologicaae 91:1068-1075.
139. Pagnocca, F. C., et al. 2010. Yeasts isolated from a fungus-growing ant nest, including the description of Trichosporon chiarellii sp. nov., an anamorphic basidiomycetous yeast. Int. J. Syst. Evol. Microbiol. 60:1454-1459.
140. Paphitou, N. I., et al. 2002. In vitro antifungal susceptibilities of Trichosporon species. Antimicrob. Agents Chemother. 46:1144-1146.
141. Perparim, K., et al. 1996. In vitro susceptibility of Trichosporon beigelii to antifungal agents. J. Chemother. 8:445-448.
142. Pfaller, M. A. 1995. Epidemiology of fungal infections: the promise of molecular typing. Clin. Infect. Dis. 20:1535-1539.
143. Pfaller, M. A., and D. J. Diekema. 2004. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J. Clin. Microbiol. 42:4419-4431.
144. Pincus, D. H., S. Orenga, and S. Chatellier. 2007. Yeast identification-past, present, and future methods. Med. Mycol. 45:97-121.
145. Ramage, G., E. Mowat, B. Jones, C. Williams, and J. Lopez-Ribot. 2009. Our current understanding of fungal biofilms. Crit. Rev. Microbiol. 35:340-345.
146. Ramani, R., S. Gromadzki, D. H. Pincus, I. F. Salkin, and V. Chaturvedi. 1998. Efficacy of API 20C and ID 32C systems for identification of common and rare clinical yeast isolates. J. Clin. Microbiol. 36:3396-3398.
147. Ramos, J. M., M. Cuenca-Estrella, F. Gutierrez, M. Elia, and J. L. Rodriguez-Tudela. 2004. Clinical case of endocarditis due to Trichosporon inkin and antifungal susceptibility profile of the organism. J. Clin. Microbiol. 42:2341-2344.
148. Reinhart, H. H., D. M. Urbanski, S. D. Harrington, and J. D. Sobel. 1988. Prosthetic valve endocarditis caused by Trichosporon beigelii. Am. J. Med. 84:355-358.
149. Reyes, C. V., M. M. Stanley, and J. W. Rippon. 1985. Trichosporon beigelii endocarditis as a complication of peritoneovenous shunt. Hum. Pathol. 16:857-859.
150. Rodrigues, M. L., F. L. Fonseca, S. Frases, A. Casadevall, and L. Nimrichter. 2009. The still obscure attributes of cryptococcal glucuronoxylomannan. Med. Mycol. 47:783-788.
151. Rodriguez-Tudela, J. L., et al. 2005. Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob. Agents Chemother. 49: 4026-4034.
152. Rodriguez-Tudela, J. L., et al. 2007. Genotype distribution of clinical isolates of Trichosporon asahii based on sequencing of intergenic spacer 1. Diagn. Microbiol. Infect. Dis. 58:435-440.
153. Roshan, A. S., C. Janaki, and B. Parveen. 2009. White piedra in a mother and daughter. Int. J. Trichol. 1:140-141.
154. Ruan, S. Y., J. Y. Chien, and P. R. Hsueh. 2009. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan. Clin. Infect. Dis. 49:11-17.
155. Ruiz-Esmenjaud, J., R. Arenas, M. Rodriguez-Alvarez, E. Monroy, and R. Felipe Fernandez. 2003. Tinea pedis and onychomycosis in children of the Mazahua Indian community in Mexico. Gaceta Med. Mexico 139:215-220.
156. Salazar, G. E., and J. R. Campbell. 2002. Trichosporonosis, an unusual fungal infection in neonates. Pediatr. Infect. Dis. J. 21:161-165.
157. Salkin, I. F., M. A. Gordon, W. A. Samsonoff, and C. L. Rieder. 1985. Blastoschizomyces capitatus, a new combination. Mycotaxon 22:375-380.
158. Sano, M., et al. 2007. Supplemental utility of nested PCR for the pathological diagnosis of disseminated trichosporonosis. Virchows Arch. 451: 929-935.
159. Schwartz, R. A. 2004. Superficial fungal infections. Lancet 364:1173-1182.
160. Serena, C., F. Gilgado, M. Marine, F. J. Pastor, and J. Guarro. 2006. Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis. Antimicrob. Agents Chemother. 50:2240-2243.
161. Serena, C., F. J. Pastor, F. Gilgado, E. Mayayo, and J. Guarro. 2005. Efficacy of micafungin in combination with other drugs in a murine model of disseminated trichosporonosis. Antimicrob. Agents Chemother. 49:497-502.
162. Shang, S. T., Y. S. Yang, and M. Y. Peng. 2010. Nosocomial Trichosporon asahii fungemia in a patient with secondary hemochromatosis: a rare case report. J. Microbiol. Immunol. Infect. 43:77-80.
163. Shimazu, K., M. Ando, T. Sakata, K. Yoshida, and S. Araki. 1984. Hypersensitivity pneumonitis induced by Trichosporon cutaneum. Am. Rev. Respir. Dis. 130:407-411.
164. Sidarous, M. G., M. V. O'Reilly, and C. E. Cherubin. 1994. A case of Trichosporon beigelii endocarditis 8 years after aortic valve replacement. Clin. Cardiol. 17:215-219.
165. Silvestre, A. M., Jr., M. A. R. Miranda, and Z. P. Camargo. 2010. Trichosporon species isolated from the perigenital region, urine and catheters of a Brazilian population. Braz. J. Microbiol. 41:628-634.
166. Spiess, B., et al. 2007. DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients. J. Clin. Microbiol. 45:3743-3753.
167. Stevenson, L. G., S. K. Drake, Y. R. Shea, A. M. Zelazny, and P. R. Murray. 2010. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinically important yeast species. J. Clin. Microbiol. 48:3482-3486.
168. St Germain, G., and D. Beauchesne. 1991. Evaluation of the MicroScan Rapid Yeast Identification panel. J. Clin. Microbiol. 29:2296-2299.
169. Sugita, T., R. Ikeda, and A. Nishikawa. 2004. Analysis of Trichosporon isolates obtained from the houses of patients with summer-type hypersensitivity pneumonitis. J. Clin. Microbiol. 42:5467-5471.
170. Sugita, T., et al. 2005. Trichosporon species isolated from guano samples obtained from bat-inhabited caves in Japan. Appl. Environ. Microbiol. 71:7626-7629.
171. Sugita, T., et al. 1997. Partial sequences of large subunit ribosomal DNA of a new yeast species, Trichosporon domesticum and related species. Microbiol. Immunol. 41:571-573.
172. Sugita, T., M. Nakajima, R. Ikeda, T. Matsushima, and T. Shinoda. 2002. Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of Trichosporon species. J. Clin. Microbiol. 40:1826-1830.
173. Sugita, T., et al. 2001. A nested PCR assay to detect DNA in sera for the diagnosis of deep-seated trichosporonosis. Microbiol. Immunol. 45:143-148.
174. Sugita, T., A. Nishikawa, R. Ikeda, and T. Shinoda. 1999. Identification of medically relevant Trichosporon species based on sequences of internal transcribed spacer regions and construction of a database for Trichosporon identification. J. Clin. Microbiol. 37:1985-1993.
175. Sugita, T., A. Nishikawa, and T. Shinoda. 1998. Rapid detection of species of the opportunistic yeast Trichosporon by PCR. J. Clin. Microbiol. 36: 1458-1460.
176. Sugita, T., A. Nishikawa, and T. Shinoda. 1994. Reclassification of Trichosporon cutaneum by DNA relatedness by using the spectrophotometric method and chemiluminometric method. J. Gen. Appl. Microbiol. 40:397-408.
177. Sugita, T., A. Nishikawa, T. Shinoda, and H. Kume. 1995. Taxonomic position of deep-seated, mucosa-associated, and superficial isolates of Trichosporon cutaneum from trichosporonosis patients. J. Clin. Microbiol. 33:1368-1370.
178. Surmont, I., et al. 1990. First report of chronic meningitis caused by Trichosporon beigelii. Eur. J. Clin. Microbiol. Infect. Dis. 9:226-229.
179. Suzuki, K., et al. 2010. Fatal Trichosporon fungemia in patients with hematologic malignancies. Eur. J. Haematol. 84:441-447.
180. Taj-Aldeen, S. J., et al. 2009. Molecular identification and susceptibility of Trichosporon species isolated from clinical specimens in Qatar: isolation of Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp. nov. J. Clin. Microbiol. 47:1791-1799.
181. Therizol-Ferly, M., et al. 1994. White piedra and Trichosporon species in equatorial Africa. II. Clinical and mycological associations: an analysis of 449 superficial inguinal specimens. Mycoses 37:255-260.
182. Thomas, D., A. Mogahed, J. P. Leclerc, and Y. Grosgogeat. 1984. Prosthetic valve endocarditis caused by Trichosporon cutaneum. Int. J. Cardiol. 5:83-87.
183. Tokimatsu, I., et al. 2007. The prophylactic effectiveness of various antifungal agents against the progression of trichosporonosis fungemia to disseminated disease in a neutropenic mouse model. Int. J. Antimicrob. Agents. 29:84-88.
184. Trentin, L., et al. 1990. Mechanisms accounting for lymphocytic alveolitis in hypersensitivity pneumonitis. J. Immunol. 145:2147-2154.
185. Uzun, O., S. Arikan, S. Kocagoz, B. Sancak, and S. Unal. 2000. Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading. Diagn. Microbiol. Infect. Dis. 38:101-107.
186. Walsh, T. J. 1990. Role of surveillance cultures in prevention and treatment of fungal infections. NCI Monogr. 9:43-45.
187. Walsh, T. J. 1989. Trichosporonosis. Infect. Dis. Clin. North Am. 3:43-52.
188. Walsh, T. J., et al. 2004. Infections due to emerging and uncommon medically important fungal pathogens. Clin. Microbiol. Infect. 10:44-66.
189. Walsh, T. J., et al. 1992. Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis. J. Infect. Dis. 166:121-133.
190. Walsh, T. J., et al. 1990. Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J. Clin. Microbiol. 28:1616-1622.
191. Watson, K. C., and S. Kallichurum. 1970. Brain abscess due to Trichosporon cutaneum. J. Med. Microbiol. 3:191-193.
192. Wolf, D. G., et al. 2001. Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units. J. Clin. Microbiol. 39:4420-4425.
193. Yamada, Y., E. Nakazawa, and K. Kondo. 1982. The coenzyme Q system in strains of Trichosporon species and related organisms. J. Gen. Appl. Microbiol. 28:355-358.
194. Yamamoto, K., et al. 1997. Experimental disseminated trichosporonosis in mice: tissue distribution and therapy with antifungal agents. J. Med. Vet. Mycol. 35:411-418.
195. Yoo, C. G., et al. 1997. Summer-type hypersensitivity pneumonitis outside Japan: a case report and the state of the art. Respirology 2:75-77.
196. Yoshida, K., M. Ando, T. Sakata, and S. Araki. 1988. Environmental mycological studies on the causative agent of summer-type hypersensitivity pneumonitis. J. Allergy Clin. Immunol. 81:475-483.
197. Yoshida, K., M. Ando, T. Sakata, and S. Araki. 1989. Prevention of summer-type hypersensitivity pneumonitis: effect of elimination of Trichosporon cutaneum from the patients' homes. Arch. Environ. Health 44:317-322.
198. Youker, S. R., and R. J. Andreozzi. 2003. White piedra: further evidence of a synergistic infection. J. Am. Acad. Dermatol. 49:746-749.